Skip to content

Clinical trials

Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Clear all

1,446 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
200120
200219
200317
200417
200538
200633
200733
200836
200948
201051
201142
201248
201336
201456
201556
201664
201773
201874
201962
202061
202161
202286
202377
202485
202570
202686

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed621
Recruiting240
Unknown status164
Terminated157
Active, not recruiting104
Not yet recruiting71
Withdrawn58
Suspended15
No longer available7
Enrolling by invitation5
Approved for marketing3
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)80
Duke University47
M.D. Anderson Cancer Center30
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins26
Memorial Sloan Kettering Cancer Center22
Mayo Clinic20
Huashan Hospital19
Wake Forest University Health Sciences17
Case Comprehensive Cancer Center15
City of Hope Medical Center14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma1,446
Glioblastoma596
Brain Neoplasms492
Astrocytoma357
Oligodendroglioma242
Gliosarcoma191
Central Nervous System Neoplasms168
Ependymoma139
Medulloblastoma106
Neoplasms102

Trials

Showing 26 to 50 of 1,446. Each trial links to its page on Pharma Observatory.

1,346 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.